The New York Entrepreneur

FDA allows temporary import of unapproved Chinese cancer drug to ease U.S. shortage

Read Time:6 Second

The FDA has given Qilu Pharmaceutical permission to ship cisplatin to the U.S. to ease a national cancer drug shortage.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post The Tell: Wall Street’s bearishness may offer another reason to buy, says BofA, as stocks rally
Next post : MongoDB stock streaks toward best day ever after big beat, forecast